Carmichael Hill & Associates, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.

Quarter-by-quarter ownership
Carmichael Hill & Associates, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$308,433
+0.9%
3,0280.0%0.14%
+3.6%
Q2 2023$305,556
+9.7%
3,0280.0%0.14%
+2.2%
Q1 2023$278,576
+1.4%
3,0280.0%0.13%
-5.0%
Q4 2022$274,700
+17.4%
3,028
-1.6%
0.14%
+11.9%
Q3 2022$234,000
-10.0%
3,0780.0%0.13%
-8.0%
Q2 2022$260,000
-9.7%
3,078
-6.2%
0.14%
+3.0%
Q1 2022$288,000
-3.4%
3,283
-3.7%
0.13%
-0.7%
Q4 2021$298,000
-4.2%
3,408
-10.5%
0.13%
-13.0%
Q3 2021$311,000
-10.4%
3,8080.0%0.15%
-12.5%
Q2 2021$347,000
+3.9%
3,808
-2.6%
0.18%
-4.3%
Q1 2021$334,000
-9.5%
3,9080.0%0.18%
-15.2%
Q4 2020$369,000
+8.5%
3,9080.0%0.22%
-4.0%
Q3 2020$340,000
-0.3%
3,9080.0%0.23%
-10.0%
Q2 2020$341,000
-2.8%
3,908
-8.2%
0.25%
-18.2%
Q1 2020$351,000
-12.9%
4,2580.0%0.31%
+7.3%
Q4 2019$403,000
+12.9%
4,258
+3.7%
0.29%
-19.0%
Q3 2019$357,000
-2.5%
4,108
+2.5%
0.35%
-2.8%
Q2 2019$366,000
-4.9%
4,0080.0%0.36%
-8.8%
Q1 2019$385,000
+9.1%
4,008
-2.4%
0.40%
-1.0%
Q4 2018$353,000
-0.3%
4,1080.0%0.40%
+17.5%
Q3 2018$354,000
+12.0%
4,108
-1.7%
0.34%
+0.6%
Q2 2018$316,000
-14.6%
4,178
-8.7%
0.34%
-15.8%
Q1 2018$370,000
-9.8%
4,578
-6.2%
0.40%
-10.0%
Q4 2017$410,0004,8780.45%
Other shareholders
NOVARTIS A G shareholders Q1 2018
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders